The reason why high-dose melphalan followed by autologous stem-cell transplantation produces good response in multiple myeloma

被引：0
|
作者：
Kuroda, Y
Sakai, A
Okikawa, Y
Munemasa, S
Katayama, Y
Takimoto, Y
Okita, H
Kimura, A
机构：
[1] Hiroshima Univ, Res Ins Rad Bio & Med, Dept Hematol & Oncol, Hiroshima 730, Japan
[2] Natl Otake Hosp, Otake, Japan
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：385B / 385B
页数：1
相关论文
共 50 条
  • [31] High-dose melphalan with autologous stem-cell rescue in metastatic rhabdomyosarcoma
    Carli, M
    Colombatti, R
    Oberlin, O
    Stevens, M
    Masiero, L
    Frascella, E
    Koscielniak, E
    Treuner, J
    Pinkerton, CR
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (09) : 2796 - 2803
  • [32] High-dose melphalan followed by two doses of bortezomib as conditioning regimen for the patients with multiple myeloma may increase response rate after autologous stem cell transplantation
    Liu, K-Y.
    Chen, H.
    Jiang, B.
    Wang, Y.
    Zhu, H. -H.
    Sun, Y. -Q.
    Lu, J.
    Bao, L.
    Huang, X. -J.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S188 - S188
  • [33] Busulfan plus melphalan versus high-dose melphalan as conditioning regimens in autologous stem cell transplantation for newly diagnosed multiple myeloma
    Byun, Ja Min
    Lee, Jayoun
    Shin, Sang-Jin
    Kang, Minjoo
    Yoon, Sung-Soo
    Koh, Youngil
    BLOOD RESEARCH, 2018, 53 (02) : 105 - 109
  • [34] Comparison of conditioning regimen toxicities among autologous stem cell transplantation eligible multiple myeloma patients: High-dose melphalan versus high-dose melphalan and bortezomib
    Aypar, Eda
    Izzettin, Fikret Vehbi
    Aki, Sahika Zeynep
    Sancar, Mesut
    Yegin, Zeynep Arzu
    Turkoz-Sucak, Gulsan
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2018, 24 (04) : 281 - 289
  • [35] Microbiota dysbiosis after high-dose melphalan and autologous hematopoietic cell transplantation in multiple myeloma
    Malard, Florent
    Battipaglia, Giorgia
    Gaugler, Beatrice
    Siblany, Lama
    van de Wyngaert, Zoe
    Bonnin, Agnes
    Dulery, Remy
    Banet, Anne
    Stocker, Nicolas
    Ricard, Laure
    Brissot, Eolia
    Mohty, Mohamad
    BONE MARROW TRANSPLANTATION, 2023, 58 (11) : 1275 - 1278
  • [36] High-dose chemotherapy with treosulfan and melphalan before autologous transplantation in multiple myeloma
    Gillich, C.
    Jeker, B.
    Aebi, Y.
    Largiader, C.
    Hayoz, M.
    Taleghani, B. Mansouri
    Bacher, U.
    Pabst, T.
    SWISS MEDICAL WEEKLY, 2021, 151 : 21 - 21
  • [37] Microbiota dysbiosis after high-dose melphalan and autologous hematopoietic cell transplantation in multiple myeloma
    Florent Malard
    Giorgia Battipaglia
    Béatrice Gaugler
    Lama Siblany
    Zoe van de Wyngaert
    Agnes Bonnin
    Rémy Duléry
    Anne Banet
    Nicolas Stocker
    Laure Ricard
    Eolia Brissot
    Mohamad Mohty
    Bone Marrow Transplantation, 2023, 58 : 1275 - 1278
  • [38] High-dose melphalan with BCNU and etoposide as preparative regimen for autologous hemopoietic stem cell transplantation in multiple myeloma (MM)
    Bernasconi, P
    Alessandrino, EP
    Colombo, AA
    Caldera, D
    Bonfichi, M
    Martinelli, G
    Malcovati, L
    Varettoni, M
    Maiocchi, M
    Brusamolino, E
    Pagnucco, G
    Castagnola, C
    Corso, A
    Bernasconi, C
    BONE MARROW TRANSPLANTATION, 1999, 23 : S133 - S133
  • [39] Long-term outcomes of high-dose melphalan and carmustine followed by autologous hematopoietic cell transplantation for multiple myeloma.
    Neppalli, Amarendra Kumar
    Shizuru, Judith
    Johnston, Laura J.
    Muffly, Lori S.
    Weng, Wen-Kai
    Negrin, Robert
    Meyer, Everett
    Laport, Ginna
    Lowsky, Robert
    Arai, Sally
    Miklos, David Bernard
    Rezvani, Andrew R.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [40] Tandem chemo-mobilization followed by high-dose melphalan and carmustine with single autologous hematopoietic cell transplantation for multiple myeloma
    Chen, A. I.
    Negrin, R. S.
    McMillan, A.
    Shizuru, J. A.
    Johnston, L. J.
    Lowsky, R.
    Miklos, D. B.
    Arai, S.
    Weng, W-K
    Laport, G. G.
    Stockerl-Goldstein, K.
    BONE MARROW TRANSPLANTATION, 2012, 47 (04) : 516 - 521
12345